Business
C21 Investments Announces Q4 Earnings Date and Provides Operational Update
C21 Investments Inc. (CSE: CXXI and OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced its expected date for reporting its audited fiscal year end financial results for the period ended March 31, 2025. The Company is also taking the opportunity to provide an operational update for the period. All currency is reported in U.S. dollars. The Company recently changed its fiscal reporting period to a March 31st year-end and will not have traditional year-
About this update from C21 Investments Inc
[{"type":"text","content":"Sequential Same Store Sales Growth Across All Dispensaries Continues Strong Outlier Performance ","length":95,"tagName":"p","attribs":{}},{"type":"text","content":"VANCOUVER, BC, May 22, 2025 /CNW/ - C21 Investments Inc. (CSE: CXXI and OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced its expected date for reporting its audited fiscal year end financial results for the period ended March 31, 2025. The Company is also taking the opportunity to provide an operational update for the period. All currency is reported in U.S. dollars. The Company recently changed its fiscal reporting period to a March 31st year-end and will not have traditional year-over-year comparable reporting periods for its fourth quarter.","length":618,"tagName":"p"},{"type":"image","alt":"C21 Investments logo (CNW Group/C21 Investments Inc.)","displaySize":"","headline":null,"caption":"C21 Investments logo (CNW Group/C21 Investments Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":106,"url":"https://media.zenfs.com/en/cnwgroup.com/ddbaedc0c2da1f761d9a20070613e64c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5jTuWzx56XYhfv_SW2J0VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE4NztjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/ddbaedc0c2da1f761d9a20070613e64c","width":400,"height":106}},"href":"https://mma.prnewswire.com/media/2694501/C21_Investments_Inc__C21_Investments_Announces_Q4_Earnings_Date.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The Company is pleased to share an update on its existing operations for its fourth quarter, ended March 31, 2025. C21 anticipates releasing audited results by June 24, 2025.","length":174,"tagName":"p"},{"type":"text","content":"For Q4 (January–March 2025), C21 reported revenue of $8.1 million, a 3% increase from $7.9 million in Q3 (October–December 2024). Compared to the previous Q4 (ended January 31, 2024), revenue grew by 24%. Gross margins for Q4 are projected at approximately 45%. Over the fiscal year (Q4 vs. Q1), C21 achieved a 23% revenue increase (see table below). The company sustained robust retail sales growth, with a 26% increase over the same period.","length":442,"tagName":"p"},{"type":"text","content":"All Silver State Relief dispensaries recorded sequential same-store sales...